NCT04580797View on ClinicalTrials.gov

Clinical Study to Evaluate Pharmacokinetics and Safety of PF-06700841 After Single and Multiple Oral Doses as Modified Release Formulations

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

October 2, 2020

Primary Completion Date

January 11, 2021

Study Completion Date

January 11, 2021

Conditions
Healthy Participants
Interventions
DRUG

PF-06700841 IR

Immediate release formulation

DRUG

PF-06700841 MR1

Modified release formulation 1

DRUG

PF-06700841 MR2

Modified release formulation 2

DRUG

PF-06700841 MR3

Modified release formulation 3

OTHER

Placebo

Matching placebo

Trial Locations (2)

33126

Quotient Sciences-Miami, Miami

33134

Quotient Sciences, Coral Gables

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY